Ryner Lai, MBBS

All articles by Ryner Lai, MBBS

• What to know about systemic mastocytosis and antidepressants

  Depression is a mental health issue that should be taken seriously, as it can worsen over time if left untreated.

• Midostaurin can yield positive outcomes for patients with aggressive SM

  Midostaurin can be an effective therapy in the management of aggressive systemic mastocytosis.

• What to ask your doctor after being diagnosed with systemic mastocytosis

  From treatments to lifestyle changes, new patients will need answers to many aspects of living with SM.

• Shape of spinal fractures can help distinguish indolent SM from osteoporosis

  Vertebral fracture shape and distribution can be used to identify patients with a likely diagnosis of indolent SM.

• What you should know about experimental therapies for SM

  While experimental therapies offer hope for future treatments, patients should manage their expectations.

• When to seek a second opinion after a systemic mastocytosis diagnosis

  The risk of a misdiagnosis in SM is low.

• Patients with SM and multiple cancers have reduced overall survival

  Multiple cancers is a risk factor for a poorer prognosis in SM.

• Subtypes explained: What is indolent systemic mastocytosis?

  Indolent SM accounts for 90% of SM cases.

• Case report: Diagnosis of indolent SM in the absence of classic symptoms

  Indolent SM may be diagnosed despite the absence of classic symptoms associated with this disorder.

• Subtypes explained: What is aggressive systemic mastocytosis?

  In aggressive SM, cancer cells may proliferate at a considerable pace.